This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights Broadcom, TotalEnergies, Lam Research, Dell Technologies and Canadian Natural Resources
by Zacks Equity Research
Broadcom, TotalEnergies, Lam Research, Dell Technologies and Canadian Natural Resources are included in this Analyst Blog.
Top Research Reports for Broadcom, TotalEnergies & Lam Research
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), TotalEnergies SE (TTE) and Lam Research Corp. (LRCX).
Here's How Much a $1000 Investment in Lam Research Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Lam Research (LRCX) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the most recent trading session, Lam Research (LRCX) closed at $938.25, indicating a +1.69% shift from the previous trading day.
Take the Zacks Approach to Beat the Market: Carrols, Nextracker, Costco in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Lam Research (LRCX) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Lam Research (LRCX) closed at $928.50, marking a -1.68% move from the previous day.
Why Is Lam Research (LRCX) Up 9.1% Since Last Earnings Report?
by Zacks Equity Research
Lam Research (LRCX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Lam Research (LRCX) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Lam Research (LRCX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Lam Research (LRCX) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Lam Research (LRCX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Most-Watched Stock Lam Research Corporation (LRCX) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching Lam Research (LRCX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
4 Stocks to Buy on Semiconductor Industry's Growth Potential
by Ritujay Ghosh
Stocks like Applied Materials, Inc. (AMAT), NVIDIA Corporation (NVDA), Micron Technology, Inc. (MU) and Lam Research Corporation (LRCX) are likely to benefit from a rebound in semiconductor sales.
Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RDVY
If You Invested $1000 in Lam Research a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Semiconductor ETFs Look Well Poised Post Q4 Earnings
by Sweta Killa
The semiconductor sector is performing well this year, driven by the expansion of artificial intelligence (AI) applications. A spate of strong earnings reports from well-known players in the space has also instilled confidence in the sector.
Lam Research Corporation (LRCX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Lam Research (LRCX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Lam Research (LRCX) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Lam Research (LRCX) and Meta Platforms (META) have performed compared to their sector so far this year.
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Lam Research (LRCX) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Lam Research (LRCX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
What Makes Lam Research (LRCX) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Lam Research (LRCX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Lam Research Corporation (LRCX) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Lam Research (LRCX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Lam Research's (LRCX) Q2 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Lam Research's (LRCX) fiscal second-quarter results reflect the impacts of sluggish memory spending.
Bulls Dominate as Economic Goldilocks Scenario Pushes Equities Into the Nosebleed Section
by Mayur Thaker
...however, underlying leading economic indicators continue to diverge from equity p/e multiples.
What's in the Cards for Lam Research (LRCX) in Q2 Earnings?
by Zacks Equity Research
Lam Research's (LRCX) fiscal second-quarter 2024 results are expected to reflect strength in 3D DRAM and advanced packaging amid a slowdown in memory spending.
Lam Research (LRCX) Moves 5.2% Higher: Will This Strength Last?
by Zacks Equity Research
Lam Research (LRCX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Top Research Reports for Microsoft, Procter & Gamble & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), The Procter & Gamble Company (PG) and AstraZeneca PLC (AZN).